Robustness of the Phoenix Biochemical Failure Definition 10 Years after Completing Dose Escalated Radiotherapy in a Cohort of Intermediate Risk Prostate Cancer Patients

G.A. Aljawi; I. Busca; R.M. MacRae; L. Eapen

doi:10.1016/j.ijrobp.2019.06.1866

Robustness of the Phoenix Biochemical Failure Definition 10 Years after Completing Dose Escalated Radiotherapy in a Cohort of Intermediate Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1866 ◽

2019 ◽

Vol 105 (1) ◽

pp. E261

Author(s):

G.A. Aljawi ◽

I. Busca ◽

R.M. MacRae ◽

L. Eapen

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Failure ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

The Phoenix

Get full-text (via PubEx)

111 Robustness of the Phoenix Biochemical Failure Definition 10 Years After Completing Dose Escalated Radiotherapy in a Cohort of Intermediate Risk Prostate Cancer Patients

Radiotherapy and Oncology ◽

10.1016/s0167-8140(19)33162-7 ◽

2019 ◽

Vol 139 ◽

pp. S48-S49

Author(s):

Ghufran Aljawi ◽

Ionut Busca ◽

Robert MacRae ◽

Libni Eapon

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Failure ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

The Phoenix

Get full-text (via PubEx)

OC-0132: Biochemical failure in low and intermediate risk prostate cancer patients after LDR Brachytherapy appear similar

Radiotherapy and Oncology ◽

10.1016/s0167-8140(15)40130-6 ◽

2015 ◽

Vol 115 ◽

pp. S62

Author(s):

A. Taggar ◽

K. Martell ◽

M. Sia ◽

S. Angyalfi ◽

S. Husain

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Failure ◽

Intermediate Risk ◽

Ldr Brachytherapy ◽

Risk Prostate Cancer

Get full-text (via PubEx)

PO-0231 Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)06390-8 ◽

2021 ◽

Vol 158 ◽

pp. S193-S194

Author(s):

T. McMullan ◽

B. Nailon ◽

D. McLaren ◽

W. Keough ◽

A. Law ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Failure ◽

Intermediate Risk ◽

Psa Kinetics ◽

Risk Prostate Cancer

Get full-text (via PubEx)

The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience

The Aging Male ◽

10.1080/13685538.2021.1948992 ◽

2021 ◽

Vol 24 (1) ◽

pp. 50-57

Author(s):

Selvi Dinçer ◽

Emre Uysal ◽

Tanju Berber ◽

Mustafa Halil Akboru

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Hypofractionated Radiotherapy ◽

Intermediate Risk ◽

Single Center ◽

Single Center Experience ◽

Risk Prostate Cancer

Get full-text (via PubEx)

PCN94 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)72183-5 ◽

2010 ◽

Vol 13 (3) ◽

pp. A41 ◽

Cited By ~ 1

Author(s):

VB Zubek ◽

F Khan

Keyword(s):

Prostate Cancer ◽

Risk Stratification ◽

Cancer Patients ◽

Cost Minimization ◽

Intermediate Risk ◽

Cost Minimization Analysis ◽

Risk Prostate Cancer

Get full-text (via PubEx)

Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapy

The Prostate ◽

10.1002/pros.24289 ◽

2021 ◽

Author(s):

Fumihiko Urabe ◽

Kenta Miki ◽

Takahiro Kimura ◽

Hiroshi Sasaki ◽

Kojiro Tashiro ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Outcomes ◽

Cancer Patients ◽

Clinical Significance ◽

Intermediate Risk ◽

Risk Prostate Cancer

Get full-text (via PubEx)

Abstract 4308: 3D nuclear telomeric signatures define circulating tumor cells (CTCs) and characterize CTC subpopulations in intermediate risk prostate cancer patients

10.1158/1538-7445.am2014-4308 ◽

2014 ◽

Author(s):

Awe A. Julius ◽

Adam Yan ◽

Nidhi Shah ◽

Klewes Ludger ◽

Alexandra Kuzyk ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Intermediate Risk ◽

Risk Prostate Cancer

Get full-text (via PubEx)

Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients

Translational Andrology and Urology ◽

10.21037/tau.2020.01.28 ◽

2020 ◽

Vol 9 (2) ◽

pp. 437-444

Author(s):

Gang Song ◽

Mingjian Ruan ◽

He Wang ◽

Zhiyong Lin ◽

Xiaoying Wang ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Predictive Model ◽

Cancer Patients ◽

Nerve Sparing ◽

Intermediate Risk ◽

Mri Findings ◽

Prostate Mri ◽

Risk Prostate Cancer

Get full-text (via PubEx)

Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.11.018 ◽

2015 ◽

Vol 91 (3) ◽

pp. 505-516 ◽

Cited By ~ 30

Author(s):

Graham D. Smith ◽

Tom Pickles ◽

Juanita Crook ◽

Andre-Guy Martin ◽

Eric Vigneault ◽

...

Keyword(s):

Prostate Cancer ◽

External Beam Radiation Therapy ◽

Biochemical Failure ◽

External Beam Radiation ◽

External Beam ◽

Intermediate Risk ◽

Beam Radiation ◽

Free Survival ◽

Risk Prostate Cancer ◽

Conventionally Fractionated

Get full-text (via PubEx)

Combined clinical characteristics and multiparametric MRI parameters for prediction of cribriform morphology in intermediate-risk prostate cancer patients

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2019.09.002 ◽

2020 ◽

Vol 38 (4) ◽

pp. 216-224 ◽

Cited By ~ 4

Author(s):

Jie Gao ◽

Qing Zhang ◽

Yao Fu ◽

Wei Wang ◽

Chengwei Zhang ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Clinical Characteristics ◽

Multiparametric Mri ◽

Intermediate Risk ◽

Risk Prostate Cancer

Get full-text (via PubEx)